American International Group, Inc. Horizon Therapeutics Public LTD CO Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $25,041 - $29,282	-253 Reduced 6.46%	3,661 $423,000
Q2 2023 Aug 04, 2023	BUY	$96.34 - $112.38 $66,956 - $78,104	695 Added 21.59%	3,914 $402,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $9,980 - $10,555	-93 Reduced 2.81%	3,219 $351,000
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $7,798 - $14,225	-125 Reduced 3.64%	3,312 $376,000
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $707 - $1,016	12 Added 0.35%	3,437 $213,000
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $62,964 - $92,273	793 Added 30.13%	3,425 $273,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $4,321 - $5,490	-50 Reduced 1.86%	2,632 $277,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $9,560 - $11,631	-97 Reduced 3.49%	2,682 $289,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $27,756 - $33,331	-302 Reduced 9.8%	2,779 $304,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $98,572 - $109,636	-1,143 Reduced 27.06%	3,081 $289,000
Q1 2021 May 07, 2021	SELL	$71.83 - $95.48 $35,843 - $47,644	-499 Reduced 10.57%	4,224 $389,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $12,730 - $16,034	-190 Reduced 3.87%	4,723 $345,000
Q3 2020 Nov 04, 2020	BUY	$55.23 - $79.93 $4,528 - $6,554	82 Added 1.7%	4,913 $382,000
Q2 2020 Aug 12, 2020	BUY	$30.2 - $56.98 $50,313 - $94,928	1,666 Added 52.64%	4,831 $269,000
Q1 2020 May 04, 2020	BUY	$24.87 - $38.56 $3,059 - $4,742	123 Added 4.04%	3,165 $94,000
Q4 2019 Feb 05, 2020	SELL	$25.43 - $36.67 $2,695 - $3,887	-106 Reduced 3.37%	3,042 $110,000
Q2 2019 Aug 23, 2019	BUY	$22.81 - $28.48 $71,805 - $89,655	3,148 New	3,148 $76,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account